/R E P E A T -- NOTICE TO THE MEDIA - Government of Canada to provide update on public health concerns related to wildfires (June 19, 2023)/
OTTAWA, ON, June 18, 2023 /CNW/ - The Honourable Jean-Yves Duclos, Minister of Health, and Government of Canada officials will provide an update on public health concerns related to wildfires.
After their remarks, they will be available to take questions from journalists.
Date June 19, 2023
Time 1:00 PM (EDT)
Location
The news conference will be held in person at:
Room 200, Sir John A. Macdonald Building 144 Wellington Street, Ottawa, Ontario
Participation in the question and answer portion of this event is in person or via Zoom, and is for accredited members of the Press Gallery only. Media who are not members of the Press Gallery may contact [email protected] for temporary access.
A teleconference line is also available for listening to the event:
Toll-free dial-in number (Canada/US): 1-866-206-0153
Local dial-in number: 613-954-9003
Participant passcode: 4995055
NOTE: To help ensure optimal simultaneous interpretation sound quality, journalists are encouraged to use a microphone (headphones/headset) or, when possible, a landline, and to avoid using speaker mode if queuing up for questions.
Regulatory News:
Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today reported its consolidated financial results for the quarter ending March 31, 2024.
"We are executing our strategy of building on our partnered...
U.S. News & World Report, the global authority in hospital rankings and consumer advice, today debuted the Best Ambulatory Surgery Centers ratings of outpatient surgical centers....
Amygdala Neurosciences (a private company) announced today that the Company has closed a new round of equity financing led by ABMRF, the Alcohol Beverage Medicines Research Foundation to fund the Company's IND-stage activities for ANS-858....
Pvolve, the fitness franchise that pairs low-impact, functional movement with resistance equipment to build strong, mobile bodies, is heading to San Francisco, following the franchise's latest development deal for two new studios in the Bay Area with...
Allozymes, a leading innovator in enzyme discovery and engineering, today announced the closing of a $15 million Series A funding round led by Seventure Partners of France and Xora Innovation of Singapore. This significant investment underscores the...